Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 4:08 pm Purchase | 2023-12-31 | 13G | AUTOLUS THERAPEUTICS PLC SPONS AUTL | Paradigm BioCapital Advisors LP | 12,611,335 7.200% | 2,512,751 (+24.88%) | Filing History |
| 2024-02-14 4:08 pm Purchase | 2023-12-31 | 13G | BICYCLE THERAPEUTICS PLC SPONS BCYC | Paradigm BioCapital Advisors LP | 3,707,001 9.800% | 2,096,336 (+130.15%) | Filing History |
| 2024-02-14 4:08 pm Purchase | 2023-12-31 | 13G | DISC MEDICINE INC IRON | Paradigm BioCapital Advisors LP | 2,385,857 9.900% | 1,149,939 (+93.04%) | Filing History |
| 2024-02-14 4:08 pm Purchase | 2023-12-31 | 13G | VIRIDIAN THERAPEUTICS INC VRDN | Paradigm BioCapital Advisors LP | 5,304,313 9.990% | 2,993,615 (+129.55%) | Filing History |
| 2024-02-14 4:08 pm Sale | 2023-12-31 | 13G | VOR BIOPHARMA INC.COM VOR | Paradigm BioCapital Advisors LP | 322,865 9.500% | -1,035 (-0.32%) | Filing History |
| 2024-02-14 4:08 pm Purchase | 2023-12-31 | 13G | NUVALENT INC NUVL | Paradigm BioCapital Advisors LP | 3,858,008 6.700% | 478,928 (+14.17%) | Filing History |
| 2024-02-14 4:08 pm Purchase | 2023-12-31 | 13G | OLEMA PHARMACEUTICALS INC OLMA | Paradigm BioCapital Advisors LP | 7,903,600 14.300% | 100,000 (+1.28%) | Filing History |
| 2024-02-14 4:08 pm Unchanged | 2023-12-31 | 13G | COMPASS PATHWAYS PLC SPONSORED CMPS | Paradigm BioCapital Advisors LP | 3,425,988 5.400% | 0 (Unchanged) | Filing History |
| 2024-02-14 4:08 pm Sale | 2024-01-26 | 13G | CORBUS PHARMACEUTICALS HOLDING CRBP | Paradigm BioCapital Advisors LP | 0 0.000% | -399,658 (Position Closed) | Filing History |
| 2024-02-05 4:21 pm Purchase | 2024-01-26 | 13G | CORBUS PHARMACEUTICALS HOLDING CRBP | Paradigm BioCapital Advisors LP | 399,658 9.000% | 399,658 (New Position) | Filing History |
| 2024-01-22 5:05 pm Purchase | 2024-01-12 | 13G | TARSUS PHARMACEUTICALS INC TARS | Paradigm BioCapital Advisors LP | 1,927,506 5.800% | 1,927,506 (New Position) | Filing History |
| 2024-01-02 5:20 pm Purchase | 2023-12-20 | 13G | COMPASS PATHWAYS PLC SPONSORED CMPS | Paradigm BioCapital Advisors LP | 3,425,988 5.400% | 3,425,988 (New Position) | Filing History |
| 2023-10-30 5:12 pm Purchase | 2023-10-19 | 13G | NUVALENT INC NUVL | Paradigm BioCapital Advisors LP | 3,379,080 5.900% | 3,379,080 (New Position) | Filing History |
| 2023-09-25 5:24 pm Purchase | 2023-09-14 | 13G | AMBRX BIOPHARMA INC SPONSORED AMAM | Paradigm BioCapital Advisors LP | 25,172,784 5.700% | 25,172,784 (New Position) | Filing History |
| 2023-09-25 4:56 pm Purchase | 2023-09-14 | 13G | DISC MEDICINE INC IRON | Paradigm BioCapital Advisors LP | 1,235,918 5.400% | 1,235,918 (New Position) | Filing History |
| 2023-09-13 5:22 pm Purchase | 2023-09-12 | 13G | OLEMA PHARMACEUTICALS INC OLMA | Paradigm BioCapital Advisors LP | 7,803,600 14.300% | 5,288,489 (+210.27%) | Filing History |
| 2023-07-21 4:44 pm Purchase | 2023-07-11 | 13G | ARCELLX INC ACLX | Paradigm BioCapital Advisors LP | 2,422,700 5.050% | 2,422,700 (New Position) | Filing History |
| 2023-07-10 5:00 pm Purchase | 2023-06-30 | 13G | AUTOLUS THERAPEUTICS PLC SPONS AUTL | Paradigm BioCapital Advisors LP | 10,098,584 5.800% | 10,098,584 (New Position) | Filing History |
| 2023-05-11 4:26 pm Purchase | 2023-05-01 | 13G | VIRIDIAN THERAPEUTICS INC VRDN | Paradigm BioCapital Advisors LP | 2,310,698 5.400% | 419,531 (+22.18%) | Filing History |
| 2023-04-10 4:33 pm Purchase | 2023-03-29 | 13G | OLEMA PHARMACEUTICALS INC OLMA | Paradigm BioCapital Advisors LP | 2,515,111 6.200% | 2,515,111 (New Position) | Filing History |